Breaking News

Alibaba Indicated to Start Trading at $84 to $87
Tweet TWEET

Verenium Corporation To Announce Third Quarter 2012 Financial Results

    Verenium Corporation To Announce Third Quarter 2012 Financial Results

PR Newswire

SAN DIEGO, Nov. 1, 2012

SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a
leading industrial biotechnology company focused on the development and
commercialization of high-performance enzymes,  today announced that it will
release 2012 third quarter financial results on Thursday, November 8, 2012
after market close. In conjunction with the release, the Company will host a
conference call with live webcast on Thursday, November 8, 2012 at 5:00 p.m.
ET.

(Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO)

The call may be accessed by dialing (877) 755-7422 (domestic) or (678)
894-3067 (international) five minutes prior to start time and providing the
passcode 55940538. A link to the live webcast may be accessed by visiting the
"Investors" section of the Company's website at http://ir.verenium.com/. A
replay of the event will be available on the Company's website approximately
two hours after the call and will be archived for 30 days.

About Verenium
Verenium, an industrial biotechnology company, is a global leader in
developing high-performance enzymes. Verenium's tailored enzymes are
environmentally friendly, making products and processes greener and more
cost-effective for industries, including the global food and fuel markets.
Read more at www.verenium.com.

Forward-Looking Statements
Statements in this press release that are not strictly historical are
"forward-looking" and involve a high degree of risk and uncertainty. These
include, but are not limited to, statements related to Verenium's technology,
products and product candidates and product pipeline, lines of business,
operations (including Verenium's ability to successfully negotiate and enter
into future collaborations and partnerships), capabilities, commercialization
activities, customer adoption rates, industry conditions, future financial
performance, and near-term and longer-term growth and prospects. Such
statements are only predictions, and actual events or results may differ
materially from those projected in such forward-looking statements. Factors
that could cause or contribute to the differences include, but are not limited
to, risks associated with Verenium's strategic focus, technologies, products
and product candidates and product pipeline (including Verenium's ability to
identify, develop and commercialize new products and product candidates,
either independently or with collaborators or partners, and market demand for
those products and product candidates), dependence on patents and proprietary
rights, protection and enforcement of its patents and proprietary rights, the
commercial prospects of the industries in which Verenium operates and sells
products, Verenium's dependence on manufacturing and/or license agreements,
its ability to achieve milestones under existing and future collaboration
agreements, the ability of Verenium and its partners to commercialize its
technologies and products (including by obtaining any required regulatory
approvals) using Verenium's technologies, the timing for launching any
commercial products and projects, the ability of Verenium and its
collaborators to market and sell any products that it or they commercialize,
the development or availability of competitive products or technologies, the
future ability of Verenium to enter into and/or maintain collaboration and
joint venture or partnership agreements and licenses on a timely basis or at
all, and risks and other uncertainties more fully described in Verenium's
filings with the Securities and Exchange Commission, including, but not
limited to, Verenium's annual report on Form 10-K for the year ended December
31, 2011 and any updates contained in its subsequently filed quarterly reports
on Form 10-Q . These forward-looking statements speak only as of the date
hereof, and Verenium expressly disclaims any intent or obligation to update
these forward-looking statements.

Contacts:

Sarah Carmody
Manager, Corporate Communications
858-431-8581
sarah.carmody@verenium.com

SOURCE Verenium Corporation

Website: http://www.verenium.com
 
Press spacebar to pause and continue. Press esc to stop.